PRODUCT DETAILS

About Parkirop 0.25mg Tablet

ROPINIROLE belongs to the group of medicines called 'Anti-parkinson drug' that is used to treat Parkinson's disease. ROPINIROLE helps improve a person's ability to move, stiffness, reduce shakiness, and improve slowed movement, and unsteadiness.  This drug is also helpful in reducing the number of episodes of not being able to do the movement ('on-off syndrome'). ROPINIROLE is also useful in treating restless legs syndrome (RLS) as this drug improves sleep by reducing the urge to move o legs. It also reduces the uncomfortable/unpleasant sensation in the legs. Parkinson's disease (PD) is a long-term movement disease in which a person initially faces tremors in just one hand that can gradually lead to stiffness or slowing of movement. Restless legs syndrome (RLS) is a condition in which a person feels an uncontrollable urge or uncomfortable sensation to move their legs. It usually occurs in the evening or nighttime when the person is lying down. Moving the legs reduces this unpleasant feeling for a short time.

ROPINIROLE has the same effects as a chemical called dopamine which occurs naturally in the body. In this way, ROPINIROLE reduces stiffness, slowed movements, shaking of parts of the body, and problems with balance. The dosing strength and right time of taking ROPINIROLE for Parkinson's patients are different from the patients of RLS. ROPINIROLE can be taken with or without a meal, but one should take it at the same time each day. This will avoid the chance of missed doses. If a person is an immediate-release ropinirole, then they should not take extended-release ropinirole at the same time of the day. However, if a person notices ROPINIROLE in their stool, then it can be a sign that their body may not have absorbed all of the medicine so they should contact the doctor for it.

Uses of Parkirop 0.25mg Tablet

Parkinson's disease, restless legs syndrome

Medicinal Benefits of Parkirop 0.25mg Tablet

ROPINIROLE is recommended for the treatment of symptoms of Parkinson's disease that may include tremors, muscle spasms, stiffness,  and poor muscle control. ROPINIROLE is also used to treat restless legs syndrome (RLS). ROPINIROLE acts by restoring the balance of dopamine in the brain. Dopamine is a natural chemical that controls the movement as well as the emotional responses of a person. By increasing the dopamine level in the body, this medicine relieves the symptoms of Parkinson's disease. In persons dealing with restless legs syndrome, this medicine improves sleep which minimizes the urge to move of legs by reducing the unpleasant sensation in the legs.

Directions for Use

Only ROPINIROLE as immediate-release is used in the treatment of Parkinson's symptoms or restless legs syndrome while Extended-release is only used in the treatment of Parkinson's symptoms. If a person is taking an immediate-release ROPINIROLE then they should not take an extended-release ROPINIROLE at the same time. The dosing strength and timing of ROPINIROLE in treating Parkinson's disease are different from the dosage and timing in treating RLS. This medicine can be taken with or without a meal and taken at the same time every day. If a person is taking it for RLS, then they should tell their doctor if symptoms get worse or did not improve with time. This medicine may take up to several weeks to show its desired results. Don't stop taking this medicine suddenly without talking with the doctor.

Side Effects of Parkirop 0.25mg Tablet

ROPINIROLE may cause some side effects including confusion, dizziness, faintness, drowsiness, falling, nausea, sleepiness, and swelling of the legs. Usually, these side effects occur because the body is adjusting to the new drug. These side effects will adjust within some time. Check with the doctor if any of these harmful effects continue or are bothersome.

Similar Drugs

For informational purposes only. Consult a doctor before taking any medicines.

In-Depth Precautions and Warning

Drug-Drug Interaction:

There are certain medications with which the use of ROPINIROLE is restricted, that may include inhibitors or inducers of CYP1A2 (carbamazepine, rifampicin), and hormone replacement therapy (testosterone), and dopamine antagonists (cabergoline, ropinirole).

Safety Advice

ALCOHOL

One should avoid drinking alcohol as it may increase the chances of drowsiness or sleepiness in the body.

LIVER

The use of ROPINIROLE is restricted in patients dealing with liver disease.

KIDNEY

No dosage adjustment is required in patients with moderate kidney disease; however, this medicine should only be given to patients dealing with kidney disease.